Moderna’s New Lower-Dose COVID-19 Vaccine Approved by FDA
New vaccine represents a step forward in development of next-generation coronavirus vaccinesContinue Reading
New vaccine represents a step forward in development of next-generation coronavirus vaccinesContinue Reading
TUESDAY, June 3, 2025 (HealthDay News) — Americans planning to travel outside the country should make sure they’re vaccinated against measles — no matter where they’re headed, U.S. health officials say. The U.S. Centers for Disease Control and Prevention (CDC) updated its guidance last week to recommend measles-mumps-rubella (MMR) shotsContinue Reading
TUESDAY, June 3, 2025 (HealthDay News) — Declining vaccination rates are making more and more U.S. children vulnerable to measles and mumps, a new study says. A national decrease in MMR (measles/mumps/rubella) vaccinations among American children has occurred since the start of the COVID-19 pandemic, researchers reported June 2 inContinue Reading
Tryptyr works by stimulating corneal sensory nerves to increase natural tear productionContinue Reading
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and olderContinue Reading
FRIDAY, May 23, 2025 (HealthDay News) — Pod-style e-cigarettes appear to be more addictive than nicotine gum, making it harder for vapers to kick the habit, a small-scale lab study has found. E-cigarettes reinforced nicotine addiction more than nicotine gum among young adults who regularly vape, results show. Specifically, theContinue Reading
THURSDAY, May 22, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies toContinue Reading
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapyContinue Reading
WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall. The new framework, announced Tuesday, says adults 65 and older, and people with certain health conditions, canContinue Reading
MONDAY, May 19, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people. The vaccine is now approved for adults ages 65 and older, or for people ages 12 to 64 who have at least oneContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.